Screening rates are insufficient to reduce cervical cancer incidence.
In this study, researchers identified 8 common themes related to challenges patients experience with ostomy self-management.
Despite widespread use of other forms of radiation therapy, consensus statements from SGO and ABS support the use of brachytherapy in the treatment of primary and recurrent cervical cancer.
Zejula, a poly(ADP-ribose) polymerase (PARP) inhibitor, is also approved for maintenance treatment in adults with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.
If crowdfunding doesn’t work, here’s how oncologists can help patients with financial toxicity.